Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.

Article  CAS  PubMed  Google Scholar 

Suzuki S, Goto A, Nakatochi M, Narita A, Yamaji T, Sawada N, Katagiri R, Iwagami M, Hanyuda A, Hachiya T, et al. Body mass index and Colorectal cancer risk: a mendelian randomization study. Cancer Sci. 2021;112(4):1579–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thrift AP, Gong J, Peters U, Chang-Claude J, Rudolph A, Slattery ML, Chan AT, Locke AE, Kahali B, Justice AE, et al. Mendelian randomization study of body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1024–31.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bezieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, et al. Mendelian randomization analysis of C-reactive protein on Colorectal cancer risk. Int J Epidemiol. 2019;48(3):767–80.

Article  PubMed  Google Scholar 

Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, et al. A comprehensive map of molecular drug targets. Nat Rev Drug Discov. 2017;16(1):19–34.

Article  CAS  PubMed  Google Scholar 

Hauser AS, Chavali S, Masuho I, Jahn LJ, Martemyanov KA, Gloriam DE, Babu MM. Pharmacogenomics of GPCR Drug targets. Cell. 2018;172(1–2):41–54. e19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, Papadimitriou N, Bishop DT, Casey G, Colorado-Yohar SM, et al. Circulating levels of testosterone, sex hormone binding globulin and Colorectal Cancer risk: observational and mendelian randomization analyses. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1336–48.

Article  PubMed  PubMed Central  Google Scholar 

Coghlin C, Murray GI. Progress in the identification of plasma biomarkers of Colorectal cancer. Proteomics. 2013;13(15):2227–8.

Article  CAS  PubMed  Google Scholar 

Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, et al. Large-scale integration of the plasma proteome with genetics and Disease. Nat Genet. 2021;53(12):1712–21.

Article  CAS  PubMed  Google Scholar 

Folkersen L, Gustafsson S, Wang Q, Hansen DH, Hedman AK, Schork A, Page K, Zhernakova DV, Wu Y, Peters J, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2(10):1135–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moncla LM, Mathieu S, Sylla MS, Bosse Y, Theriault S, Arsenault BJ, Mathieu P. Mendelian randomization of circulating proteome identifies actionable targets in Heart Failure. BMC Genomics. 2022;23(1):588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo S, Clarke SLN, Ramanan AV, Thompson SD, Langefeld CD, Marion MC, Grom AA, Schooling CM, Gaunt TR, Yeung SLA, et al. Platelet glycoprotein ib alpha-chain as a putative therapeutic target for juvenile idiopathic arthritis: a mendelian randomization study. Arthritis Rheumatol. 2021;73(4):693–701.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao SS, Bovijn J, Hughes DM, Sha T, Zeng C, Lyu H. Genetically predicted vitamin K levels and risk of osteoarthritis: mendelian randomization study. Semin Arthritis Rheum. 2022;55:152030.

Article  CAS  PubMed  Google Scholar 

Sleiman PM, Grant SF. Mendelian randomization in the era of genomewide association studies. Clin Chem. 2010;56(5):723–8.

Article  CAS  PubMed  Google Scholar 

Smith GD, Ebrahim S. Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of Disease? Int J Epidemiol. 2003;32(1):1–22.

Article  PubMed  Google Scholar 

Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018, 7.

Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, LeFaive J, VandeHaar P, Gagliano SA, Gifford A, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50(9):1335–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, Taylor AE, Davies NM, Howe LD. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465–78.

Article  PubMed  PubMed Central  Google Scholar 

Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, Gutteridge A, Erola P, Liu Y, Luo S, et al. Phenome-wide mendelian randomization mapping the influence of the plasma proteome on complex Diseases. Nat Genet. 2020;52(10):1122–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bubenik JL, Miniard AC, Driscoll DM. Alternative transcripts and 3’UTR elements govern the incorporation of selenocysteine into selenoprotein S. PLoS ONE. 2013;8(4):e62102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hariton E, Locascio JJ. Randomised controlled trials - the gold standard for effectiveness research: study design: randomised controlled trials. BJOG. 2018;125(13):1716.

Article  PubMed  PubMed Central  Google Scholar 

Lawlor DA. Commentary: two-sample mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016;45(3):908–15.

Article  PubMed  PubMed Central  Google Scholar 

Shibata T, Arisawa T, Tahara T, Ohkubo M, Yoshioka D, Maruyama N, Fujita H, Kamiya Y, Nakamura M, Nagasaka M, et al. Selenoprotein S (SEPS1) gene – 105G > A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population. BMC Gastroenterol. 2009;9:2.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Zhu Y, Zhou Y, Jiang H, Chen Z, Lu B, Shen X. The SELS rs34713741 polymorphism is Associated with susceptibility to Colorectal Cancer and gastric Cancer: a Meta-analysis. Genet Test Mol Biomarkers. 2020;24(12):835–44.

Article  CAS  PubMed  Google Scholar 

Kim HS, Yoon G, Do SI, Kim SJ, Kim YW. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma. Oncotarget. 2016;7(12):15187–99.

Article  PubMed  PubMed Central  Google Scholar 

Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Critical role for Tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against Tumor development. J Exp Med. 2002;195(2):161–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M, Vessella RL. Osteoprotegerin and rank ligand expression in Prostate cancer. Urology. 2001;57(4):611–6.

Article  CAS  PubMed  Google Scholar 

De Toni EN, Thieme SE, Herbst A, Behrens A, Stieber P, Jung A, Blum H, Goke B, Kolligs FT. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon Cancer. Clin Cancer Res. 2008;14(15):4713–8.

Article  PubMed  Google Scholar 

Holen I, Cross SS, Neville-Webbe HL, Cross NA, Balasubramanian SP, Croucher PI, Evans CA, Lippitt JM, Coleman RE, Eaton CL. Osteoprotegerin (OPG) expression by Breast cancer cells in vitro and breast tumours in vivo–a role in tumour cell survival? Breast Cancer Res Treat. 2005;92(3):207–15.

Article  CAS  PubMed  Google Scholar 

Holen I, Croucher PI, Hamdy FC, Eaton CL. Osteoprotegerin (OPG) is a survival factor for human Prostate cancer cells. Cancer Res. 2002;62(6):1619–23.

CAS  PubMed  Google Scholar 

Naumann U, Wick W, Beschorner R, Meyermann R, Weller M. Expression and functional activity of osteoprotegerin in human malignant gliomas. Acta Neuropathol. 2004;107(1):17–22.

Article  CAS  PubMed  Google Scholar 

Pettersen I, Bakkelund W, Smedsrod B, Sveinbjornsson B. Osteoprotegerin is expressed in colon carcinoma cells. Anticancer Res. 2005;25(6B):3809–16.

CAS  PubMed  Google Scholar 

Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K. Clinical significance of osteoprotegerin expression in human Colorectal cancer. Clin Cancer Res. 2011;17(8):2444–50.

Article